Pfizer (PFE) Debt Ratio (2009 - 2026)
Pfizer (PFE) posted quarterly Debt Ratio of 0.31 for Q1 2026, up 3.79% year-over-year from 0.3 in Q1 2025, and down 0.52% quarter-over-quarter from 0.31 in Q4 2025.
Pfizer (PFE) Debt Ratio (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Debt Ratio for 18 consecutive years, with 0.31 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio rose 3.79% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 0.31 (up 3.79% YoY), while the FY2025 annual figure was 0.31, up 3.11% from the prior year.
- Debt Ratio slipped to 0.31 in Q1 2026 per PFE's latest filing, from 0.31 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.32 in Q2 2024 and bottomed at 0.18 in Q4 2022.
- Historically, Debt Ratio has averaged 0.28 across 5 years, with a median of 0.3 in 2025.
- Annual changes were most pronounced in 2022 — Debt Ratio dropped 21.01% — and 2023, when it soared 74.68%.
- Pfizer's Debt Ratio stood at 0.18 in 2022, then surged by 74.68% to 0.32 in 2023, then declined by 5.21% to 0.3 in 2024, then advanced by 3.11% to 0.31 in 2025, then retreated by 0.52% to 0.31 in 2026.
- Business Quant data shows PFE's Debt Ratio at 0.31 in Q1 2026, 0.31 in Q4 2025, and 0.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -0.31 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 0.31 |
| Mar 29, 2026 | 0.31 |
| Dec 31, 2025 | 0.31 |
| Sep 28, 2025 | 0.30 |
| Jun 29, 2025 | 0.30 |
| Mar 30, 2025 | 0.30 |
| Dec 31, 2024 | 0.30 |
| Sep 29, 2024 | 0.31 |
| Jun 30, 2024 | 0.32 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.32 |
| Jul 2, 2023 | 0.30 |
| Apr 2, 2023 | 0.18 |
| Dec 31, 2022 | 0.18 |
| Jul 3, 2022 | 0.21 |
| Apr 3, 2022 | 0.20 |
| Dec 31, 2021 | 0.21 |
| Oct 3, 2021 | 0.86 |
| Jul 4, 2021 | 0.23 |
| Apr 4, 2021 | 0.25 |